Rejecting the Cloudy Logic of EPA Ozone Rules


By Merrill Matthews


The Environmental Protection Agency just missed a court-ordered deadline to announce which regions of the country are complying with an Obama-era ozone rule. The agency says it needs more time to make that determination.

Green activists are livid. The Environmental Defense Fund accused the agency of "allowing vulnerable communities to suffer the consequences of polluted air while Administrator Pruitt stalls."

Ozone is the main ingredient in smog. So one might assume that the nation's city dwellers are struggling to breathe. Only the activists' rhetoric is breathless, though. Ozone levels have dropped by a third since 1980.

This precipitous drop didn't stop the Obama administration from issuing a strict new ozone rule in 2015. The regulation requires states to limit ground-level ozone concentrations to 70 parts per billion. Previous standards issued in 2008 had set acceptable ozone levels at 75 ppb. States are poised to waste billions adhering to these new rules -- all to address a problem that has been getting better for a decades.

Regulators are working with states to ease the compliance burden as much as possible. But the EPA can't nix the regulation on its own. Only Congress can do so.

The new regulations aren't needed. The United States has already slashed air pollution dramatically. Since 1970, levels of six common air pollutants have dropped by an average of 70 percent across the nation, even as economic output jumped over 240 percent. Levels of carbon monoxide alone have fallen by 84 percent since 1990, while lead concentrations have dropped by 85 percent.

The 2015 regulation, known as the National Ambient Air Quality Standards for Ozone, would create an immense compliance burden on many regions of the country. In roughly 180 counties, ozone levels still exceed the 2008 requirement of 75 ppb. The new 2015 standard would move the goalposts. More than 958 counties -- roughly one-third of all counties -- could be classified as "nonattainment" areas if the standard is changed to 70 ppb.

They'll face severe penalties for failing to meet the new standards. The federal government can freeze funding for transportation projects. And it can force factories and other buildings in nonattainment areas to install expensive emission reduction technologies.

As a result, local economies would pay a significant price. In 2015, the EPA claimed that compliance would cost states, excluding California, $1.4 billion by 2025.

The actual costs will likely be far higher. As recently as 2011, the agency calculated the annual cost of meeting the 70 ppb standard at between $19 and 25 billion. An analysis from the economic consulting firm NERA estimates that new ozone standards could cost the economy $270 billion annually between now and 2040.

Why would federal regulators choose to ignore the crippling costs associated with their rules? Because they're required to. The Clean Air Act prohibits the EPA from considering costs when determining air-quality standards.

Congress knows the updated ozone rules will devastate the economy. This summer, the House passed the Ozone Standards Implementation Act of 2017 to delay the 2015 standards. It's now up to the Senate to do the same.

Over the last few decades, America has made extraordinary progress in ridding the air of harmful pollutants -- including ozone. Imposing draconian ozone standards -- at immense economic cost -- is irrational and irresponsible.

Merrill Matthews is a resident scholar with the Institute for Policy Innovation in Dallas, Texas. Follow him on Twitter @MerrillMatthews

More Resources


04/28/2024
1968 Protests Should Serve as a Warning to Today's Democrats


more info


04/28/2024
Is the Worst Yet to Come?
By Steve Huntley April 28, 2024 This and that. Random thoughts and observations about current events. Trigger alert! What follows might harm the psyche of the woke. Perhaps those sensitive souls should retreat to a safe space, which I suspect will be Judenfrei. Peaceful protest is a hallowed right and tradition in America. These days, however, that right, which achieved ... Read More

more info


04/28/2024
Who's on Trial, a Former President or a Mob Boss?
It's downright disturbing to contemplate the similarities between the Donald's hush money trial and that of an organized crime don.

more info


04/28/2024
Public Worried Dems Engaging in Politicized Lawfare


more info


04/28/2024
Even Bill Barr Should Prefer Joe Biden
Even Bill Barr Should Prefer Joe Biden

more info


04/28/2024
The Economy: From Bad to Worse--Stagflation
Consumer spending has slowed, capital investment slowed, inventories slumped - and the trade deficit widened.

more info


04/28/2024
Biden's Dilemma: NC Voters Are Sour on Economy
All indicators are up, except the one that matters most to Biden's reelection

more info


04/28/2024
Campus Leaders Must Show Courage, Stand Up to Hatred
Signs at Columbia University read Go Back to Poland, calling for the Jewish community to return to the horrific death camps of the Holocaust.

more info


04/28/2024
The Campus-Left Occupation That Broke Higher Education
Elite colleges are now reaping the consequences of promoting a pedagogy that trashed the postwar ideal of the liberal university.

more info


04/28/2024
Education Apocalypse Now?
The Ivy League Hits An Iceberg.

more info


04/28/2024
The Strange Death of the Family
The world is sleepwalking towards a depopulation crisis.

more info


04/28/2024
Alvin Bragg and the Art of Not Taking the Law Too Seriously


more info


04/28/2024
Justice Alito Is Holding Trump to a Different Standard
I mentioned it in passing in my Friday column, but I was struck - disturbed, really - by one specific

more info


04/28/2024
Shock and Awe on the Campaign Trail


more info


04/28/2024
Disillusionment Plagues Young Latinos in Swing States


more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."